Related Experiment Video
Updated: Aug 26, 2025

12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.5K
Living with primary brain calcification with PDGFB variants: A qualitative study
Tomiko Takeuchi1, Hisami Aoyagi1, Yoshimi Kuwako1
1Faculty of Nursing, Toyama Prefecture University, Toyama City, Toyama, Japan.
Plos One
|October 7, 2022
Summary
Patients with PDGFB-variant primary brain calcification experience shock, anxiety, and alienation. Persistent headaches are a major stressor, differing from other variants, highlighting unique patient challenges.
Area of Science:
- Neurodegenerative Diseases
- Genetics
- Qualitative Research
Background:
- Primary brain calcification (PBC) is a rare, intractable neurodegenerative disease with no effective treatments.
- Key causative genes include SLC20A2 and PDGFB.
- Psychological distress is common in PBC patients due to the disease's nature.
Purpose of the Study:
- To explore the lived experiences of patients diagnosed with PDGFB-variant primary brain calcification.
- To identify unique challenges and coping mechanisms in this patient population.
Main Methods:
- A qualitative study involving five patients over 21 years old.
- Semi-structured interviews conducted over three years.
- Inductive qualitative analysis of interview data.
Main Results:
- Seven main categories of experience were identified, including initial shock, hereditary anxiety, symptom-related anxiety, gratitude for care, acceptance, alienation, and lifestyle modification.
- Persistent headaches, even with analgesics, were a significant stressor, distinguishing PDGFB variants.
- Unique findings included anxiety about hereditary risk and feelings of alienation.
Conclusions:
- Patients with PDGFB-variant PBC face distinct psychological and physical challenges, including severe headaches and hereditary concerns.
- Understanding these experiences is crucial for developing targeted support and care strategies.
- Further research is needed to address the specific needs of PDGFB-variant PBC patients.

